// App-Quantinova.ai

BSH2020‐PO‐207 : First report of post‐transplant autoimmune hyperlipidaemia and treatment with rituximab

Researchers

Presenter

  • W. Y. C. Sin

Principal Investigators

  • J. Cavenagh

  • M. Smith

  • R. Ayling

  • K. Nakajima

Medical Centers

  • Hematology

  • Clinical Biochemistry, Barts Health NHS TRUST, London, UK

  • Graduate School of Medicine, Gunma University, Maebashi, Gunma, Japan

Locations

  • United Kingdom

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Autoimmune (AI)

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Autoimmune hemolytic anemia

  • Acute myelocytic leukemia

  • Sjogren's syndrome

  • Lymphocytopenia

  • Diabetes

  • Lupus

  • Graft-versus-host disease

Biomarkers

  • Cluster of Differentiation 2AP

  • Dopamine transporter

  • Glycosylphosphatidylinositol

  • Immunoglobulin G

  • L-plastin

  • Body mass index

Drug/Treatment

  • Atorvastatin

  • Prednisolone

  • Cyclosporine A

  • Fenofibrate

  • Rapacan

  • Rituximab

  • Dextrose Intravenous

  • lipase

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved